Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004122
Status:
COMPLETED
Last Update Posted:
2013-02-01
First Post:
1999-12-10
Brief Title:
BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer
Sponsor:
Roswell Park Cancer Institute
Organization:
Roswell Park Cancer Institute
Organization Data
Organization:
Roswell Park Cancer Institute
Class:
OTHER
Study ID:
CDR0000067348
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Roswell Park Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |